Cytomegalovirus Lymphadenitis Mimicking Relapsed Lymphoma After <scp>CD19</scp> Chimeric Antigen Receptor ( <scp>CAR</scp> ) T Cell Therapy
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Mohammed A. Raja (ORCID: https://orcid.org/0000-0003-4324-5748)
- José F. Camargo (ORCID: https://orcid.org/0000-0001-9584-5011)
- Trent Peng Wang
- Mark S. Goodman (ORCID: https://orcid.org/0000-0002-8366-6865)
- Lazaros J. Lekakis (ORCID: https://orcid.org/0009-0008-2077-7032)
- Adriana Jiménez (ORCID: https://orcid.org/0000-0001-8542-4870)
- Noa G. Holtzman (ORCID: https://orcid.org/0000-0002-5706-1109)
- Jay L. Spiegel
- Michele I. Morris (ORCID: https://orcid.org/0000-0002-4479-8726)
- Lubna Osman‐Kardash
- Amer Beitinjaneh
- Rodrigo Santoscoy‐Valencia
- Damian J. Green
- Denise Pereira
Institutions
- University of Miami (US)
- Sylvester Comprehensive Cancer Center (US)
Publication Details
- Journal
- Apmis
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/apm.70172
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 24.20